CAS RN: 97739-46-3
meCgPPh, 1,3,5,7-Tetramethyl-8-phenyl-2,4,6-trioxa-8-phosphatricyclo[3.3.1.13,7]decane
Product Availability
Choose a grade to view its available package options.
1 package records1 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20250725 |
5g |
In stock |
Shanghai | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 1g, 5g, 25g, 100g, 0.25g, 10g
- Available purity: >97%
- Inventory rows with stock: 6
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 97739-46-3
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 1g |
>97% |
5
In Stock
|
Shanghai |
Inquiry |
| 5g |
>97% |
2
In Stock
|
Shenzhen |
Inquiry |
| 25g |
>97% |
2
In Stock
|
Shanghai |
Inquiry |
| 100g |
>97% |
2
In Stock
|
Shanghai |
Inquiry |
| 0.25g |
>97% |
1
In Stock
|
Shanghai |
Inquiry |
| 10g |
>97% |
1
In Stock
|
Hong Kong |
Inquiry |
97739-46-3 / 1,3,5,7-tetramethyl-8-phenyl-2,4,6-trioxa-8-phosphatricyclo[3.3.1.13,7]decane
Standard CAS: 97739-46-3
Multi CAS: Yes
Basic Information
CAS
97739-46-3
Multi CAS
Yes
Molecular Formula
C16H21O3P
Molecular Weight
292.310000
Exact Mass
292.122832
InChI
InChI=1S/C16H21O3P/c1-13-10-15(3)19-14(2,17-13)11-16(4,18-13)20(15)12-8-6-5-7-9-12/h5-9H,10-11H2,1-4H3
InChIKey
AVVSJWUWBATQBX-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
20
Aromatic heavy atom count
6
Fraction Csp3
0.62
Rotatable bonds
1
H-bond acceptors
3
Molar refractivity
79.11
TPSA
27.69
LogP / Solubility
WLOGP
3.53
MLOGP
3.12
XLogP3
2.5
Consensus LogP
3.05
Log S (ESOL)
-4.03
Class (ESOL)
Slightly soluble
Log S (Ali)
-4.51
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-4.61
Class (SILICOS-IT)
Slightly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-2
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
8.5